The Citing articles tool gives a list of articles citing the current article. The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
This article has been cited by the following article(s):
Immunogenicity and Immunoprotection of PCV2 Virus-like Particles Incorporating Dominant T and B Cell Antigenic Epitopes Paired with CD154 Molecules in Piglets and Mice
Keke Wu, Wenshuo Hu, Bolun Zhou, Bingke Li, Xiaowen Li, Quanhui Yan, Wenxian Chen, Yuwan Li, Hongxing Ding, Mingqiu Zhao, Shuangqi Fan, Lin Yi and Jinding Chen International Journal of Molecular Sciences 23(22) 14126 (2022) https://doi.org/10.3390/ijms232214126
Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate
Ileanet Ávalos, Thailin Lao, Elsa María Rodríguez, Yasser Zamora, Alianet Rodríguez, Ailyn Ramón, Gilda Lemos, Ania Cabrales, Monica Bequet-Romero, Dionne Casillas, Ivan Andújar, Luis Ariel Espinosa, Luis Javier González, Yanitza Alvarez, Yamila Carpio and Mario Pablo Estrada Vaccines 10(6) 897 (2022) https://doi.org/10.3390/vaccines10060897
Enhanced immunogenicity of foot and mouth disease DNA vaccine delivered by PLGA nanoparticles combined with cytokine adjuvants
Co-expression of Interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice
Corrigendum to “Efficacy of E2 glycoprotein fused to porcine CD154 as a novel chimeric subunit vaccine to prevent classical swine fever virus vertical transmission in pregnant sows”
Global Virology I - Identifying and Investigating Viral Diseases
Hana Van Campen, Guillermo Risatti, Manuel Borca, et al. Global Virology I - Identifying and Investigating Viral Diseases 361 (2015) https://doi.org/10.1007/978-1-4939-2410-3_14
CD40L-Adjuvanted DNA/Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus SIV239 Vaccine Enhances SIV-Specific Humoral and Cellular Immunity and Improves Protection against a Heterologous SIVE660 Mucosal Challenge
CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses
Peptide vaccine candidates against classical swine fever virus: T cell and neutralizing antibody responses of dendrimers displaying E2 and NS2–3 epitopes
Marta Monsó, Joan Tarradas, Beatriz G. de la Torre, et al. Journal of Peptide Science 17(1) 24 (2011) https://doi.org/10.1002/psc.1292
Current strategies for subunit and genetic viral veterinary vaccine development
Enhancement of the immunogenicity of an infectious laryngotracheitis virus DNA vaccine by a bicistronic plasmid encoding glycoprotein B and interleukin-18
Enhancement of DNA vaccine (P12A3C-pcDNA) efficacy against foot-and-mouth disease by coadministration of interleukin-18-expressing (IL18 pcDNA) plasmid in guinea-pigs
K. Siva Reddy, D. Muralidhar Rao, Natarajan Badrinaryana, Veluvarthy V.S. Suryanaryana and Golla R. Reddy FEMS Immunology & Medical Microbiology 60(3) 261 (2010) https://doi.org/10.1111/j.1574-695X.2010.00739.x
Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization
Porcine B-cell activating factor promotes anti-FMDV antibodies in vitro but not in vivo after DNA vaccination of pigs
Fabio Bergamin, Leslie Saurer, Viviane Neuhaus, Kenneth C. McCullough and Artur Summerfield Veterinary Immunology and Immunopathology 120(3-4) 115 (2007) https://doi.org/10.1016/j.vetimm.2007.06.021
Novel marker vaccines against classical swine fever